Adverum biotechnologies, inc. (ADVM)
Income statement / Quarterly
Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Collaboration and license revenue

-

250

-

-

70

833

493

216

-

463

463

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration and license revenue

-

-

-

-

-

-

-

-

-

-

-

462

488

395

307

265

960

953

203

203

203

204

135

30

-

-

Government grant revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

150

Total revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

30

150

Operating expenses:
Research and development

11,374

9,944

8,970

10,131

11,642

14,480

11,217

12,794

12,014

10,272

8,492

9,061

7,898

8,362

7,955

7,455

7,192

7,523

5,126

5,621

7,226

5,746

3,094

910

550

661

General and administrative

8,279

7,389

7,132

5,576

5,187

4,826

9,179

5,368

4,042

4,762

4,064

7,989

4,777

6,146

5,114

8,318

5,374

7,631

4,959

4,143

3,380

2,398

1,494

726

258

194

Impairment of intangible asset

-

-

-

-

-

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill impairment charge

-

-

-

-

-

-

-

-

-

-

-

-

-

394

49,120

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

19,653

17,333

16,102

15,707

16,829

24,306

20,396

18,162

16,056

15,034

12,556

17,050

23,875

14,902

62,189

15,773

15,139

15,154

10,085

9,764

10,606

8,144

4,588

1,636

808

855

Operating loss

-19,653

-17,083

-16,102

-15,707

-16,759

-23,473

-19,903

-17,946

-15,595

-14,571

-12,093

-16,588

-23,387

-14,507

-61,882

-15,508

-14,179

-14,201

-9,882

-9,561

-10,403

-7,940

-4,453

-1,606

-778

-705

Other income:
Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

4

14

28

20

Other income, net

-

-

1,148

1,218

-

-

1,093

746

806

742

663

489

218

206

222

116

85

117

116

52

11

-26

0

-6

-4

6

Change in fair value of embedded derivative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9

6

Change in fair value of warrant liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1

290

433

37

12

8

Loss on extinguishment of related-party convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-204

-

-

-

Other income, net

-

965

-

-

-

1,265

-

-

-

-

-

489

218

206

222

116

85

117

116

52

12

-316

-641

-57

-35

-16

Net loss before income taxes

-

-16,118

-

-

-

-22,208

-

-

-

-13,829

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax benefit

-

-

-

-

-

-1,250

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-18,925

-16,118

-14,954

-14,489

-15,659

-20,958

-18,810

-17,200

-14,789

-13,829

-11,430

-16,099

-

-14,301

-61,660

-15,392

-

-14,084

-9,766

-9,509

-10,391

-8,256

-5,094

-1,663

-813

-721

Deemed dividend

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,230

-

-

-

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,256

-8,324

-

-813

-721

Other comprehensive income:
Net unrealized gain on marketable securities

6

4

20

3

39

53

59

17

-80

35

-49

-88

6

-6

0

6

-18

2

45

-35

-

-

-

-

-

-

Foreign currency translation adjustment

14

-11

-4

42

17

0

54

-75

-332

-183

-141

-118

11

-23

-4

14

10

-17

0

-8

-

-15

-1

-

-

-

Foreign currency translation adjustment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4

15

Comprehensive loss

-18,905

-16,125

-14,938

-14,444

-15,603

-20,905

-18,697

-17,258

-15,201

-13,977

-11,620

-16,305

-22,377

-14,330

-61,664

-15,372

-14,102

-14,099

-9,721

-9,552

-10,392

-8,271

-5,095

-1,663

-809

-736

Net loss per share - basic and diluted

-0.30

-0.25

-0.23

-0.23

-0.24

-0.34

-0.30

-0.30

-0.32

-0.32

-0.27

-0.38

-0.46

-0.35

-1.76

-0.57

-0.55

-0.55

-0.38

-0.38

0.76

-0.50

-2.27

-0.45

-0.22

-0.20

Weighted-average common shares outstanding-basic and diluted

65,059

64,484

63,740

63,125

63,260

62,454

62,366

57,420

46,110

43,381

43,009

42,144

41,429

41,416

35,044

27,095

25,789

25,685

25,555

24,887

22,864

16,394

3,673

3,673

3,673

3,672